David Ternant
Impact in
- Immunology top 2%
- Biosimilars and Bioanalytical Methods
- Rheumatology top 2%
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 36
- Immunology 29
- Biosimilars and Bioanalytical Methods 23
- Co-authors
- Gilles Paintaud (89 shared papers)Hervé Watier (25 shared papers)Denis Mulleman (26 shared papers)Philippe Goupille (16 shared papers)Charlotte Magdelaine–Beuzelin (4 shared papers)Danielle Degenne (8 shared papers)Théodora Bejan‐Angoulvant (20 shared papers)Émilie Ducourau (8 shared papers)
- Journals
- British Journal of Clinical Pharmacology (17 papers)Clinical Pharmacokinetics (14 papers)Therapeutic Drug Monitoring (9 papers)mAbs (4 papers)European Journal of Clinical Pharmacology (4 papers)
- Partner nations
- FranceUnited StatesBelgium
In The Last Decade
David Ternant
120 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 94
- Immunology 777
- Rheumatology 479
- Genetics 289
- Radiology, Nuclear Medicine and Imaging 722
- Genetics 857
Countries citing papers authored by David Ternant
This map shows the geographic impact of David Ternant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Ternant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Ternant more than expected).
Fields of papers citing papers by David Ternant
This network shows the impact of papers produced by David Ternant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Ternant. The network helps show where David Ternant may publish in the future.
Co-authors
The 25 scholars most cited alongside David Ternant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 125 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 421 | |
| 2 | 2012 | 297 | |
| 3 | 2008 | 166 | |
| 4 | 2011 | 139 | |
| 5 | 2009 | 137 | |
| 6 | 2008 | 104 | |
| 7 | 2005 | 102 | |
| 8 | 2006 | 93 | |
| 9 | An enzyme-linked immunosorbent assay for therapeutic drug monitoring of Cetuximab | 2009 | 91 |
| 10 | 2015 | 90 | |
| 11 | 2011 | 87 | |
| 12 | 2014 | 85 | |
| 13 | 2017 | 83 | |
| 14 | 2013 | 75 | |
| 15 | 2015 | 69 | |
| 16 | 2016 | 61 | |
| 17 | 2010 | 58 | |
| 18 | 2009 | 57 | |
| 19 | 2014 | 57 | |
| 20 | 2016 | 57 |
About David Ternant
David Ternant is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology, Rheumatology, Transplantation and Oncology, having authored 125 papers that have together received 4k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (36 papers), Biosimilars and Bioanalytical Methods (23 papers), Rheumatoid Arthritis Research and Therapies (16 papers), Inflammatory Bowel Disease (12 papers), Renal Transplantation Outcomes and Treatments (8 papers), Lymphoma Diagnosis and Treatment (8 papers), Colorectal Cancer Treatments and Studies (7 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). The work is most often cited by research in Immunology (777 citations), Rheumatology (479 citations), Genetics (289 citations), Radiology, Nuclear Medicine and Imaging (722 citations) and Genetics (857 citations). David Ternant has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Gilles Paintaud, Hervé Watier, Denis Mulleman, Philippe Goupille, Charlotte Magdelaine–Beuzelin, Danielle Degenne, Théodora Bejan‐Angoulvant, Émilie Ducourau, Thierry Lecomte and Gert Van Assche. Their work appears in journals such as British Journal of Clinical Pharmacology, Clinical Pharmacokinetics, Therapeutic Drug Monitoring, mAbs and European Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.